| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 1.48% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 2.51% | |
| Healthcare | 96.01% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 24.81 | -0.12 (-0.48%) | 17.13 - 25.30 | 18.6 thousand (Above Avg) |
Market data as of 11:35AM 05/21/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that correspond (before fees and expenses) to the price and yield performance of the Dow Jones Emerging Markets Health Care Titans 30 IndexSM. Under normal circumstances, the fund will invest at least 80% of its net assets in securities of Emerging Markets Health Care companies that are included in the fund's Health Care underlying index and generally expects to be substantially invested at such times, with at least 95% of its net assets invested in those securities. The fund is non-diversified.
| Open | 24.82 |
|---|---|
| Previous Close | 24.93 |
| Day's Range | 24.76 - 24.93 |
| Avg Volume (10 Day) | 10.0K |
| Total Assets | $6.06M |
| Expense Ratio | 7.79% |
| Yield (Trailing 12 Mo.) | 0.16% |
| Fund Inception | 06/23/2011 |
| Timeframe | HGEM | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 5.30% | 1.93% | 3.38% |
| 3 Month | 9.19% | 7.18% | 10.04% |
| Year-to-Date | 10.53% | 12.74% | 17.90% |
| 1 Year | 25.94% | 16.89% | 26.16% |
| 3 Year | -- | 12.80% | 17.80% |
| 5 Year | -- | 5.21% | 13.29% |
| 10 Year | -- | 7.88% | 8.84% |
| Since Inception | 12.26% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 1.48% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 2.51% | |
| Healthcare | 96.01% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 0.00% |
| Company | YTD Return | % of Assets |
|---|---|---|
| Sun Pharmaceuticals Industries Ltd. | -- | 10.24% |
| Aspen Pharmacare Holdings PLC | 17.07% | 10.07% |
| Life Healthcare Group Holdings Ltd. | -- | 6.97% |
| MR | 18.75% | 5.60% |
| RDY | 12.44% | 4.87% |
| PT Kalbe Farma Tbk | -- | 4.83% |
| Netcare Limited | -- | 4.37% |
| Cipla Ltd. | -- | 4.29% |
| Mediclinic International Limited | -- | 4.19% |
| Sinopharm Group Co., Ltd. H Shares | -0.51% | 4.08% |
| Valuation | HGEM | Category Range |
|---|---|---|
| Price/Earnings | 25.66 | |
| Price/Book | 3.23 | |
| Price/Sales | 1.99 | |
| Price/Cash Flow | 18.72 | |
| Dividend Yield | 1.06 | |
| LT Earnings | 17.87 | |
| Historical Earnings | 20.05 | |
| Sales Growth | 11.83 | |
| Cash-Flow Growth | 13.48 | |
| Book-Value Growth | 14.38 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
| Beta | -- |
|---|---|
| Standard Deviation | -- |
| Alpha | -- |
| Sharpe Ratio | -- |
| Mean | -- |
| R-Squared | -- |
| Pretax Return | -- |
|---|---|
| Tax-adjusted Return | -- |
| Tax Cost Ratio | -- |
| Potential Cap Gains | 14.42% |